Şunu aradınız:: dpp (İngilizce - Maltaca)

dpp-4 inhibitor, atc code:
kategorija farmakoterapewtika: inibitur dpp- 4, kodiċi atc:

dpp-4 inhibition by vildagliptin is not affected by age.
l-impediment ta’ dpp-4 minn vildagliptin mhux effettwat mill-età.

dpp-4 inhibition by vildagliptin is not affected by gender.
l-impediment ta’ dpp-4 minn vildagliptin mhux effettwat miss-sess.

once-daily regimen + metformin  dpp-iv inhibitor
f'kors ta' darba kuljum + insulina aspart biex ikopri l-ħtiġijiet tal-insulina f'ħin l-ikel.

dipeptidyl peptidase 4 (dpp-4) inhibitors, atc code:
impedituri dipeptidyl peptidase (dpp- 4), kodiċi atc:

the dpp-4 inhibitors are a class of agents that act as incretin enhancers.
l-impedituri dpp-4 huma klassi ta’ mediċini li jaħdmu billi jtejbu l-azzjoni ta’ incretin.

alogliptin is a dipeptidyl-peptidase-4 (dpp 4) inhibitor.
alogliptin huwa inibitur ta’ dipeptidyl-peptidase-4 (dpp 4).

inhibition of dpp-4 remained above 81% at 24 hours after 14 days of dosing.
l-impediment ta’ dpp-4 baqa’ ogħla minn 81% f’24 siegħa wara 14-il jum ta’ dożaġġ.

vildagliptin, a member of the islet enhancer class, is a potent and selective dpp-4 inhibitor.
vildagliptin, membru tal-klassi islet enhancer, huwa inibitur qawwi u silettiv dpp-4.

dpp-4 contributes partially to the hydrolysis of vildagliptin based on an in vivo study using dpp-4 deficient rats.
dpp-4 jikkontribwixxi parzjalment għall-isdroliżi ta’ vildagliptin ibbażat minn studju in vivo bl-użu ta’ firien li ma kellhomx dpp-4.

in patients with type 2 diabetes, administration of saxagliptin inhibited dpp-4 enzyme activity throughout a 24-hour period.
f'pazjenti bid-dijabete tat-tip 2, l-għoti ta' saxagliptin inibixxa l-attività tal-enzimu dpp-4 matul perjodu ta' 24 siegħa.

vildagliptin, a member of the islet enhancer class, is a potent and selective dipeptidyl-peptidase-4 (dpp-4) inhibitor.
vildagliptin, membru tal-klassi li jtejjeb l-islet, huwa impeditur qawwi u silettiv ta’ dipeptidyl- peptidase-4 (dpp-4).